5 results
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... or ABLC (5 mg/kg ... Meningoencephalitis #IDSA ... #Treatment #management ... #meningitis #cryptococcus
Initial assessment and management of coma in pediatric population.

Airway - is it secure? 
Breathing — is
assessment and management ... Scale Exposure - e.g ... poisoning - diabetes ... - septicaemia/meningitis
IDSA - Diabetic Foot Infections - Suggested Route, Setting, and Duration of Antibiotic Therapy, by Clinical
IDSA - Diabetic ... infected tissue (eg ... postoperatively ≥3 mo #IDSA ... #Diabetic #Foot ... #pharmacology #management
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Transplant Recipients
Induction therapy:
 • liposomal AmB (3–4 mg/kg per
IDSA Treatment Recommendations ... or ABLC (5 mg/kg ... Meningoencephalitis #IDSA ... #Treatment #management ... #meningitis #cryptococcus
IDSA - Approach to Treating a Patient With Diabetic Foot Osteomyelitis
When to consider a trial of
IDSA - Approach ... a Patient With Diabetic ... renal failure) #Diabetic ... #nonoperative #management ... #IDSA